SynthesisBMC veterinary research2025
Prevalence of antimicrobial resistance in equine-associated Pseudomonas aeruginosa: a systematic review and meta-analysis.
Synthesis in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The escalating issue of antimicrobial resistance (AMR) in Pseudomonas aeruginosa (P. aeruginosa), particularly in the equine context, poses a significant threat to veterinary and public health. This systematic review and meta-analysis aimed to assess the current landscape of AMR in P. aeruginosa strains isolated from equine sources. Adhering to the PRISMA guidelines, a comprehensive literature search was conducted, and data from eligible studies were extracted and synthesized. The review included 10 articles reporting on 1624 P. aeruginosa isolates. High resistance rates were found for several antimicrobial classes, with particular concern for increasing resistance to imipenem, amikacin, and ceftiofur. The study also identifies significant temporal trends and regional variations in resistance patterns. Asia reported the highest average resistance rates, suggesting potential misuse of antimicrobials in the region. The most effective antimicrobials were found to be aztreonam, fosfomycin, ciprofloxacin, and ceftazidime. However, the generalizability of these findings is limited by the small number of eligible studies (n = 10) and the scarcity of isolates for certain antimicrobial classes. The findings of this review highlight the critical need for innovative strategies, stringent antimicrobial stewardship, and comprehensive risk assessment to combat the escalating threat of AMR in equine-associated P. aeruginosa and preserve the efficacy of our existing antimicrobial agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.